Mankind Pharma Partners with SpiceJet to Elevate Brand Awareness Mankind Pharma Partners with SpiceJet to Elevate Brand Awareness

Press Release

Explore our unique initiatives & partnerships

Mankind Pharma Partners with SpiceJet to Elevate Brand Awareness

Mankind Pharma, a reputed global pharmaceutical firm, is set to collaborate with SpiceJet, one of India’s major domestic airlines to elevate brand awareness. The spectacular display on SpiceJet’s plane with Mankind’s logo will not only capture the brand’s journey and vision but also serve as a testament to Mankind Pharma’s dedication to innovation and raising the bar in the healthcare industry.

This association marks the next step in propagating Mankind Pharma’s vision of ensuring international quality medicines to all. Mankind Pharma has taken a pioneering step by introducing 120 DMF quality API medicines in the Indian market, which conform to stringent international standards.

Mr. Rajeev Juneja, Vice Chairman and Managing Director, Mankind Pharma, expressed his excitement and shared, "At Mankind Pharma, our continuous endeavour has been to improve lives through groundbreaking healthcare solutions. Our goal is to enable access to international quality API medicines for everyone. This has led to the introduction of 120 DMF quality API in our medicines."

The medicines in the USA comply with stringent USFDA’s norms for quality, safety and effectiveness; defined by DMF (Drug Master File). The Drug Master File (DMF) has all the information on an API (Active Pharmaceutical Ingredient/Raw Material for medicines). It provides extensive data on the manufacturing, stability, quality, packaging, purity and impurity profile for authorities to ensure that medicines are up to international standards in terms of quality.

This campaign, therefore, aims to raise awareness about DMF-grade API medicines and the need for affordable yet international quality healthcare. Mankind hopes to capture even larger audiences and elevate its brand image through thrilling airport promotions and media spotlights. By leveraging this partnership, Mankind Pharma plans to create a lasting impact on consumers, reaffirming its position as a trusted pharmaceutical company in the Indian industry.

About the collaboration, Debojo Maharshi, Chief Business Officer, SpiceJet expressed, “On behalf of SpiceJet, I congratulate Mankind Pharma for their vision of introducing 120 DMF quality API medicines in India, which is a testament to their commitment to quality and excellence in the pharmaceutical industry. We are proud to once again partner with them in celebrating this achievement by wrapping two of our Boeing 737 aircraft in their livery. SpiceJet’s unique flying billboards have become an integral part of the promotions for various top brands, and we are happy to offer this innovative and effective medium to Mankind Pharma once again. We look forward to a long and fruitful association with them.”

Two Spice Jet planes displaying Mankind’s vision of providing international quality API medicines will take off on the 21st of September. This will be a part of the larger campaign, which is aligned with one of the core focuses of the G20 India Presidency’s health initiatives, Universal Healthcare. The visibility and reach offered by SpiceJet’s extensive network provide an ideal platform to raise awareness about Mankind’s vision. This collaboration strategically leverages SpiceJet’s wide customer base and market presence to effectively communicate the message of Mankind Pharma’s dedication to excellence in medicine production.

About Mankind Pharma

Mankind Pharma (BSE: 543904 | NSE: MANKIND) is one of the largest pharmaceutical companies in India, which focuses on the domestic market with its Pan India presence. Mankind operates at the intersection of the Indian pharmaceutical formulations and consumer healthcare sectors with the aim of providing international quality products at affordable prices.

The company is a leading player in the domestic pharmaceuticals business present across acute and chronic therapeutic areas. This includes products for anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/CNS, VMN and respiratory diseases, among others with a strategy to increase market presence/ share for chronic ailments. In the consumer healthcare business, the company operates in the condoms, pregnancy detection, emergency contraceptives, antacid powders, vitamin and mineral supplements and anti-acne preparations categories, among others, with several category-leading brands. The company has 25 manufacturing facilities across India and has over four thousand manufacturing personnel as of December 31, 2022. Manufacturing a wide range of dosage forms, including tablets, capsules, syrups, vials, ampoules, blow fill seals, soft and hard gels, eye drops, creams, contraceptives and other over-the-counter products.

Mankind has a consistent track record of product innovation. As of December 31, 2022, the company had a team of over 600 scientists and dedicated in-house R&D centres with six units located in Haryana, Maharashtra, Himachal Pradesh and Uttarakhand.

Reach out to us at PR Desk

Read more on our Partner sites: Dais World | The Progress Catalyst

Get rewarded for your reading habits on the Dais World app!